| Research On Nicotinamide Riboside Supplement Support in MDS (ROSS Trial) (NCT07579429) | University of Colorado, Denver | 2026-05-20 |
| Clonal Hematopoiesis Chemotherapy and Radiation Effects Study (NCT07675967) | Dana-Farber Cancer Institute | 2025-04-04 |
| Early Intervention in High Risk CCUS (NCT06802146) | Lachelle D. Weeks, MD, PhD | 2025-02-07 |
| A Phase 2 Study Evaluating Olutasidenib in Patients With IDH1-mutated Clonal Cytopenia of Undetermined Significance and Lower-risk Myelodysplastic/Syndromes/Chronic Myelomonocytic Leukemia. (NCT06566742) | M.D. Anderson Cancer Center | 2024-12-10 |
| Enasidenib for Patients With Clonal Cytopenia of Undetermined Significance and Mutations in IDH2A Decentralized Trial (NCT06240754) | Washington University School of Medicine | 2024-10-10 |
| Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms (NCT06063486) | University of Southern California | 2024-03-01 |
| Statins in Patients With Clonal Cytopenia of Undetermined Significance (CCUS) and Myelodysplastic Syndromes (MDS) (NCT05483010) | Washington University School of Medicine | 2024-02-19 |
| Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES Study (NCT06295965) | University of Washington | 2024-01-02 |
| Canakinumab for the Prevention of Progression to Cancer in Patients With Clonal Cytopenias of Unknown Significance, IMPACT Study (NCT05641831) | Uma Borate | 2023-02-06 |
| Ivosidenib for Patients With Clonal Cytopenia of Undetermined Significance and Mutations in IDH1 (NCT05030441) | Washington University School of Medicine | 2022-04-01 |
| Acquired Pyruvate Kinase Deficiency In Clonal Myeloid Neoplasms (NCT04902833) | Massachusetts General Hospital | 2022-02-01 |
| A Study of Enasidenib in People With Clonal Cytopenia of Undetermined Significance (NCT05102370) | Memorial Sloan Kettering Cancer Center | 2021-10-06 |
| CHIP/CCUS Natural History Protocol (NCT04102423) | National Heart, Lung, and Blood Institute (NHLBI) | 2020-03-03 |
| Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia (NCT03418038) | Mayo Clinic | 2018-03-23 |
| Pre-myeloid Cancer and Bone Marrow Failure Clinic Study (NCT02958462) | Mayo Clinic | 2017-01-16 |